Self-Selection Effects in Smokers Attending Lung Cancer Screening: A 9.5-Year Population-Based Cohort Study in Varese, Italy

Background: We hypothesize that mortality risk profile of participants and nonparticipants in nonrandomized lung cancer (LC) screening of smokers may be different. Methods: In 1997, a population-based cohort of 5815 smokers of Varese Province was invited to nonrandomized LC screening by annual chest x-ray examination for 4 years. LC risk factors and screening participation rate were recorded. Except for screening, the whole cohort received usual care. After 9.5-year observation, we compared mortality of participants versus nonparticipants by assessing age-standardized all-cause mortality rate ratio (MRR) and disease group-specific MRR with 95% confidence intervals (95% CI). Results: Self-selected screening participants were 21% of cohort. Participants were younger (p < 0.001), were more frequently current smokers (p = 0.019), had more pack-years of smoking (p < 0.0001), and had higher rate of LC family history (p < 0.0001) and of occupational LC risk (p < 0.0001) relative to nonparticipants. In logistic regression analysis familial LC, occupational risk and pack-years smoked were significant predictors of participation in screening and of developing LC. Participants displayed a healthy effect, as shown by all-cause MRR = 0.67 (95% CI, 0.53–0.84), all cancers except LC MRR = 0.61 (95% CI, 0.41–0.91), cardiovascular diseases MRR = 0.38 (95% CI, 0.22–0.63), and noncancer disease other than cardiovascular or respiratory MRR = 0.57 (95% CI, 0.34–0.92). The LC mortality (MRR = 1.40; 95% CI, 1.03–1.91) was higher in participants relative to nonparticipants (p = 0.031). Conclusion: The selection effect in LC screening participants was dual: healthy effect and higher LC mortality. In assessing the overall effectiveness of LC screening on a population level, a higher LC mortality risk in participants should be considered.

[1]  P. Prorok,et al.  Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. , 2007, American journal of epidemiology.

[2]  M. Kaneko,et al.  Evaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, Japan. , 1999, Lung cancer.

[3]  E. Hahn,et al.  Perceived risk and interest in screening for lung cancer among current and former smokers. , 2006, Research in nursing & health.

[4]  T. Eisen,et al.  Systematic review of the relationship between family history and lung cancer risk , 2005, British Journal of Cancer.

[5]  L. Holmberg,et al.  A 9-Year Follow-up Study of Participants and Nonparticipants in Sigmoidoscopy Screening: Importance of Self-Selection , 2008, Cancer Epidemiology Biomarkers & Prevention.

[6]  G. Dionigi,et al.  Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival , 2005, Thorax.

[7]  P. Marcus,et al.  Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project. , 2009, Lung cancer.

[8]  Satomi Takahashi,et al.  A case–control study for evaluating the efficacy of mass screening program for lung cancer in miyagi prefecture, Japan , 2001, Cancer.

[9]  G. Dionigi,et al.  Lung cancer screening in cigarette smokers in the province of Varese, Italy. , 2000, Cancer.

[10]  G. Silvestri,et al.  Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts , 2007, Thorax.

[11]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[12]  S. Ciatto,et al.  Prostate cancer specific mortality in the Florence screening pilot study cohort 1992-1993. , 2006, European journal of cancer.

[13]  L. Holmberg,et al.  Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer , 2007, International journal of cancer.

[14]  T. Sobue A case–control study for evaluating lung cancer screening in Japan , 2000, Cancer.

[15]  K. Kiura,et al.  A case-control study of lung cancer screening in Okayama Prefecture, Japan. , 2000, Lung cancer.

[16]  S. Ciatto,et al.  Misclassification of breast cancer as cause of death in a service screening area , 2009, Cancer Causes & Control.

[17]  A. Richardson,et al.  Breast Cancer Screening: The Effect of Self Selection for Screening on Comparisons of Randomised Controlled Trials , 1997, Journal of medical screening.

[18]  William J Kostis,et al.  Overdiagnosis in chest radiographic screening for lung carcinoma , 2003, Cancer.

[19]  W F Taylor,et al.  Lung cancer screening: the Mayo program. , 1986, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[20]  F E Alexander,et al.  Study design of randomized controlled clinical trials of breast cancer screening. , 1997, Journal of the National Cancer Institute. Monographs.